felodipine has been researched along with Disease Exacerbation in 4 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity is a significant risk factor for hypertension and the cardiovascular sequelae of hypertension." | 2.69 | The effect of weight loss intervention on antihypertensive medication requirements in the hypertension Optimal Treatment (HOT) study. ( Adair, CT; Anderson, DC; Cameron, ME; Jones, DW; King, NS; Miller, ME; Willoughby, DL; Wofford, MR, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karthigeyan, D | 1 |
| Siddhanta, S | 1 |
| Kishore, AH | 1 |
| Perumal, SS | 1 |
| Ågren, H | 1 |
| Sudevan, S | 1 |
| Bhat, AV | 1 |
| Balasubramanyam, K | 1 |
| Subbegowda, RK | 1 |
| Kundu, TK | 1 |
| Narayana, C | 1 |
| Wong, ND | 1 |
| Teng, W | 1 |
| Abrahamson, D | 1 |
| Willner, R | 1 |
| Henein, N | 1 |
| Franklin, SS | 1 |
| Kashyap, ML | 1 |
| Rosenzweig, B | 1 |
| Kukes, G | 1 |
| Detrano, RC | 1 |
| Jones, DW | 1 |
| Miller, ME | 1 |
| Wofford, MR | 1 |
| Anderson, DC | 1 |
| Cameron, ME | 1 |
| Willoughby, DL | 1 |
| Adair, CT | 1 |
| King, NS | 1 |
| Herlitz, H | 1 |
| Harris, K | 1 |
| Risler, T | 1 |
| Boner, G | 1 |
| Bernheim, J | 1 |
| Chanard, J | 1 |
| Aurell, M | 1 |
3 trials available for felodipine and Disease Exacerbation
| Article | Year |
|---|---|
Noninvasive tracking of coronary atherosclerosis by electron beam computed tomography: rationale and design of the Felodipine Atherosclerosis Prevention Study (FAPS).
Topics: Aged; Anticholesteremic Agents; Calcium; Calcium Channel Blockers; Coronary Artery Disease; Disease | 1995 |
The effect of weight loss intervention on antihypertensive medication requirements in the hypertension Optimal Treatment (HOT) study.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bloo | 1999 |
The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blocke | 2001 |
1 other study available for felodipine and Disease Exacerbation
| Article | Year |
|---|---|
SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool.
Topics: Animals; Aurora Kinase A; Aurora Kinase B; Binding, Competitive; Cell Cycle; Cell Death; Disease Pro | 2014 |